Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Clinical and Experimental Immunology
|
November 1, 1973
Rosetting of human red blood cells to thymocytes and thymus-derived cells
G Baxley, G B Bishop, A G Cooper, et al.
Marine Pollution Bulletin
|
June 22, 2017
Beach litter sourcing: A trawl along the Northern Ireland coastline
A T Williams, P Randerson, C Allen, et al.
Archives of Internal Medicine
|
July 1, 1984
Pulmonary hemorrhage in lupus erythematosus without evidence of an immunologic cause
M R Desnoyers, S Bernstein, A G Cooper, et al.
European Journal of Biochemistry
|
January 2, 1976
Allosteric activation of the hydrolysis of specific substrates by chymotrypsin
B F Erlanger, N H Wassermann, A G Cooper, et al.
The Biochemical Journal
|
July 1, 1970
Phenothiazine-N-carbonyl chloride, a specific inactivator of chymotrypsin
B F Erlanger, S M Vratsanos, N H Wassermann, et al.
Journal of the National Cancer Institute
|
November 1, 1975
Reversible loss in suspension culture of a major cell-surface glycoprotein of the TA3-Ha mouse tumor
D K Miller, A G Cooper, M C Brown, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1974
Relationship of carcinoembryonic antigen to blood substances A and i: evidence that the antigenic sites are on different molecules
A G Cooper, M C Brown, M E Kirch, et al.
Clinical and Experimental Immunology
|
April 1, 1973
Quantitation of surface-membrane and intracellular gamma, mu and kappa chains of normal and neoplastic human lymphocytes
A G Cooper, M C Brown, H A Derby, et al.
Biochemistry
|
February 25, 1975
Evidence that the major cell suface glycoprotein of the TA3-Ha carcinoma contains the Vicia graminea receptor sites
J F Codington, A G Cooper, M C Brown, et al.
Journal of the National Cancer Institute
|
July 1, 1979
Loss of strain specificity of the TA3-St subline: evidence for the role of epiglycanin in mouse allogeneic tumor growth
A G Cooper, J F Codington, D K Miller, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Clinical and Experimental Immunology
|
November 1, 1973
Rosetting of human red blood cells to thymocytes and thymus-derived cells
G Baxley, G B Bishop, A G Cooper, et al.
Marine Pollution Bulletin
|
June 22, 2017
Beach litter sourcing: A trawl along the Northern Ireland coastline
A T Williams, P Randerson, C Allen, et al.
Archives of Internal Medicine
|
July 1, 1984
Pulmonary hemorrhage in lupus erythematosus without evidence of an immunologic cause
M R Desnoyers, S Bernstein, A G Cooper, et al.
European Journal of Biochemistry
|
January 2, 1976
Allosteric activation of the hydrolysis of specific substrates by chymotrypsin
B F Erlanger, N H Wassermann, A G Cooper, et al.
The Biochemical Journal
|
July 1, 1970
Phenothiazine-N-carbonyl chloride, a specific inactivator of chymotrypsin
B F Erlanger, S M Vratsanos, N H Wassermann, et al.
Journal of the National Cancer Institute
|
November 1, 1975
Reversible loss in suspension culture of a major cell-surface glycoprotein of the TA3-Ha mouse tumor
D K Miller, A G Cooper, M C Brown, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1974
Relationship of carcinoembryonic antigen to blood substances A and i: evidence that the antigenic sites are on different molecules
A G Cooper, M C Brown, M E Kirch, et al.
Clinical and Experimental Immunology
|
April 1, 1973
Quantitation of surface-membrane and intracellular gamma, mu and kappa chains of normal and neoplastic human lymphocytes
A G Cooper, M C Brown, H A Derby, et al.
Biochemistry
|
February 25, 1975
Evidence that the major cell suface glycoprotein of the TA3-Ha carcinoma contains the Vicia graminea receptor sites
J F Codington, A G Cooper, M C Brown, et al.
Journal of the National Cancer Institute
|
July 1, 1979
Loss of strain specificity of the TA3-St subline: evidence for the role of epiglycanin in mouse allogeneic tumor growth
A G Cooper, J F Codington, D K Miller, et al.
Page
of 5